Karo Pharma AB (OSTO:KARO BTA) 3-Year Revenue Growth Rate : 5.00% (As of Jun. 2022)

View and export this data going back to . Start your Free Trial

What is Karo Pharma AB 3-Year Revenue Growth Rate?

Karo Pharma AB's Revenue per Share for the three months ended in Jun. 2022 was kr0.00.

During the past 12 months, Karo Pharma AB's average Revenue per Share Growth Rate was -20.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 5.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 21.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Karo Pharma AB was 127.60% per year. The lowest was -59.20% per year. And the median was 6.30% per year.

Competitive Comparison of Karo Pharma AB's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Karo Pharma AB's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Karo Pharma AB's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Karo Pharma AB's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Karo Pharma AB's 3-Year Revenue Growth Rate falls into.

Karo Pharma AB 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Karo Pharma AB (OSTO:KARO BTA) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Karo Pharma AB 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Karo Pharma AB's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Karo Pharma AB (OSTO:KARO BTA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Karo Pharma AB (OSTO:KARO BTA) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Klara Norra Kyrkogata 33, Stockholm, SWE, 111 22

Website

https://www.karopharma.com

Karo Pharma AB is a healthcare corporation. It is engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are Ibux, Paracet, Dosett, Allevo, and Swereco. It operates in the segment of development and sale of products to pharmacies, digital distribution channels and food stores. The company carries its business operations in Sweden and internationally, of which the majority of the revenue is generated from Sweden and Norway.

Karo Pharma AB (OSTO:KARO BTA) Headlines

No Headlines